Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review

Other authors

Institut Català de la Salut

[Coloretti I, Genovese A] Anesthesia and Intensive Care Medicine, Policlinico Di Modena, University of Modena and Reggio Emilia, Italy. [Teixeira JP] Divisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA. [Cherian A] Anesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry, India. [Ferrer R] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Landoni G] Anesthesia and Intensive Care, IRCCS San Rafaele Scientifc Institute, Milan, Italy

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-02-26T12:42:51Z

2024-02-26T12:42:51Z

2024-02-21



Abstract

Angiotensina II; Shock sèptic; Vasopressors


Angiotensin II; Septic shock; Vasopressors


Angiotensina II; Shock séptico; Vasopresores


Patients with septic shock who experience refractory hypotension despite adequate fluid resuscitation and high-dose noradrenaline have high mortality rates. To improve outcomes, evidence-based guidelines recommend starting a second vasopressor, such as vasopressin, if noradrenaline doses exceed 0.5 µg/kg/min. Recently, promising results have been observed in treating refractory hypotension with angiotensin II, which has been shown to increase mean arterial pressure and has been associated with improved outcomes. This narrative review aims to provide an overview of the pathophysiology of the renin-angiotensin system and the role of endogenous angiotensin II in vasodilatory shock with a focus on how angiotensin II treatment impacts clinical outcomes and on identifying the population that may benefit most from its use.

Document Type

Article


Published version

Language

English

Publisher

BMC

Related items

Journal of Anesthesia, Analgesia and Critical Care;4

https://doi.org/10.1186/s44158-024-00150-w

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)